ViQUAL Medical Technology LLC is a breakthrough diagnostic-technology company developing the next generation of noninvasive human-health detection systems.
We are combining spectroscopy, advanced sensors, AI-driven signal analysis, and quantum-enhanced detection concepts to create medical tools capable of identifying disease—without a needle, without pain, and without delay.
Core Mission Statement
ViQUAL’s mission is to revolutionize human diagnostics by making early detection faster, safer, and more accurate using patented, noninvasive technologies.
ViQUAL gets its trade secrets based upon Better Life Technologies that has biomedical R&D research focused on developing noninvasive diagnostic platforms focusing on HIV, Cancer, and Diabetes built upon our U.S. patented technologies (U.S. Patent Nos. 8,659,435 B2 and 10,959,651 B1 and a plethora of patent pending technologies). Finally, our ultimate mission is to change the face of healthcare to make diagnostics simpler and more efficient. Better Life and ViQUAL are two separate companies.
Applications of our developing technology have applications in areas of health science from diagnostics to the science of aging.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.